Pharmaceutical firms grappling with drug sales boost

Pharmaceutical companies began to refrain from using rebates as a marketing tool amid the government’s threat to punish firms involved in unlawful drug marketing activities. But this is not the end of the story.

Drug companies heeded the government’s threat, with their all-out efforts to diversify revenue sources and nurture new growth engines.

However, the problem is that many companies...